NGS In-Depth Focus 2017
Posted: 12 September 2017 | Drug Target Review | No comments yet
Next-generation sequencing is a crucial part of the scientist’s toolkit. This in-depth focus compares the strengths and weaknesses of a range of NGS technologies and examines the benefits and challenges of using it in infectious disease diagnosis…
Articles within in this NGS In-Depth Focus:
- NGS: empowering infectious disease research beyond reality
Pushpanathan Muthuirulan (National Institutes of Health), Pooja Sharma (Catholic University of America) - How next-generation sequencing is opening the door for drug discovery
Kim Judge (Wellcome Trust Sanger Institute)
Also includes:
- Expert view: The future of single-cell sequencing
Dan Norton (Bio-Rad Laboratories) - Expert view: Overcoming NGS obstacles
Dr Sam Rulli (QIAGEN) - Expert view: Single-cell sequencing in basic research and clinical applications
Suvarna Gandlur (Takara Bio USA) - Expert view: Advances in NGS technology
Dumitru Brinza (Thermo Fisher Scientific)
The digital version of this In-Depth Focus is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Drug Discovery, Next Generation Sequencing (NGS)
Related organisations
Bio-Rad Laboratories, PerkinElmer, Qiagen, Takara Bio, Thermo Fisher Scientific
Related people
Kim Judge, Pooja Sharma, Pushpanathan Muthuirulan